Open house Arzneimittelrabattverträge Denosumab, ATC M05BX04
Original notice title
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Denosumab, ATC M05BX04
Opportunity Score
Why this score?
Opportunity
65 / 100
Complexity
20 / 100
Risk factors
Open-house contracts automatically cease if a competitive discount contract for Denosumab is concluded at federal or st...
Incorrect submission (e.g., missing signatures, not meeting format requirements) may delay contract start.
Submission deadline in 8 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Strong opportunityKey Facts
- Framework procurement
- Supplies contract
- 1 lot
- Duration until Oct 2026
- Supply of Denosumab (ATC M05BX04) pharmaceuticals.
- Conclude non-exclusive discount agreements with AOK Bayern under §130a Abs. 8 SGB V.
Show full summary
Open-house model for non-exclusive discount agreements on Denosumab (ATC M05BX04) with AOK Bayern. All qualifying pharmaceutical companies can join on identical terms. Contract runs from 01.11.2024 to 31.10.2026, with possible earlier termination if a competitive discount contract comes into effect. No selection or award criteria – everyone who meets eligibility gets a contract.
Risks
Open-house contracts automatically cease if a competitive discount contract for Denosumab is concluded at federal or st...
Incorrect submission (e.g., missing signatures, not meeting format requirements) may delay contract start.
Submission deadline in 8 days
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Tenderer must be a pharmaceutical company (pharmazeutischer Unternehmer).
Administrative
- Submit signed contract and annex 'Festlegung der vertragsgegenständlichen Arzneimittel'.
- Submit signed self-declaration of reliability (Eigenerklärung zur Zuverlässigkeit).
Requirements may be incomplete.
Buyer
Location
München, DEU
Website
Buyer profile
Identifier
DE811695320
Activity
Health
Lots (1)
LOT-0001
Open house Arzneimittelrabattverträge Denosumab, ATC M05BX04
Non-exclusive discount agreements for Denosumab. All interested pharmaceutical companies that meet the eligibility criteria can sign identical contracts. Contracts can be concluded anytime until 05.09.2026. Place of performance: Bayern (DE212).
Location
Duration
Category
Deadline
Award details
Siehe kurze Beschreibung
Show original TED data
Original TED description
Siehe kurze Beschreibung
Procurement Details
- Publication date
- 16 Sep 2024
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 557186-2024
Documents (2)
Similar tenders
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta
Opportunity Score
Why this score?
Opportunity
65 / 100
Complexity
20 / 100
Risk factors
Open-house contracts automatically cease if a competitive discount contract for Denosumab is concluded at federal or st...
Incorrect submission (e.g., missing signatures, not meeting format requirements) may delay contract start.
Submission deadline in 8 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications